​

Relay Therapeutics Ownership | Who Owns Relay Therapeutics?

OverviewForecastRevenueFinancialsChart

Relay Therapeutics Ownership Summary

Relay Therapeutics is owned by 21.69% institutional investors, 1.57% insiders, and 76.74% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 16.29% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.41% of its assets in Relay Therapeutics shares.

RLAY Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRelay Therapeutics21.69%1.57%76.74%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sb investment advisers (uk)27.90M16.29%$145.66M
Commodore capital lp17.00M9.91%$169.15M
Casdin capital14.42M8.40%$143.46M
Blackrock10.54M7.94%$68.74M
Blackrock funding, inc. /de12.98M7.56%$129.10M
Perceptive advisors9.75M5.68%$97.02M
Vanguard group9.69M5.62%$81.99M
Tang capital management8.07M4.71%$42.12M
Bellevue group7.80M4.54%$77.56M
State street6.23M3.63%$62.02M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Casdin capital14.42M10.86%$143.46M
Commodore capital lp17.00M9.79%$169.15M
Foresite capital management iv1.00M4.20%$9.95M
Nextech invest5.53M3.87%$54.99M
Nextech invest3.85M2.57%$15.85M
Perceptive advisors9.75M1.90%$97.02M
Bellevue group7.80M1.85%$77.56M
Bioimpact capital2.36M1.81%$23.48M
Tang capital management8.07M1.62%$42.12M
Exome asset management278.30K1.43%$2.77M

Top Buyers

HolderShares% AssetsChange
Perceptive advisors9.75M1.90%7.85M
Fmr3.70M0.00%3.53M
Adage capital partners gp2.59M0.04%2.09M
Ecor1 capital1.90M0.80%1.90M
Casdin capital14.42M10.86%1.42M

Top Sellers

HolderShares% AssetsChange
Point72 asset management---13.86M
Braidwell lp---3.50M
Eventide asset management---2.68M
Finepoint capital lp---2.12M
Jacobs levy equity management---1.68M

New Positions

HolderShares% AssetsChangeValue
Ecor1 capital1.90M0.80%1.90M$18.95M
Marshall wace, llp941.83K0.01%941.83K$9.37M
Vanguard fiduciary trust900.55K0.00%900.55K$8.96M
Norges bank837.42K0.00%837.42K$7.08M
Panagora asset management818.04K0.03%818.04K$8.14M

Sold Out

HolderChange
Tfc financial management-1.00
Aster capital management (difc)-10.00
Capital performance advisors llp-11.00
Nelson, van denburg & campbell wealth management group-18.00
First command advisory services-25.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026123-46.05%37,220,983-78.55%210.21%66-44.07%31-45.61%
Dec 31, 2025150-26.11%57,894,103-65.17%330.36%73-15.12%39-38.10%
Sep 30, 2025192-3.52%164,241,668-1.23%951.02%79-25.47%6326.00%
Jun 30, 2025203-3.33%170,787,0214.95%991.08%106-3.64%54-5.26%
Mar 31, 202513-93.60%21,465,711-86.91%120.09%8-93.89%2-94.44%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BB Biotech AG Ord7.38M4.41%-
Vanguard Total Stock Mkt Idx Inv5.76M3.31%19.89K
Vanguard US Total Market Shares ETF4.89M2.88%904.00K
iShares Russell 2000 ETF3.33M1.76%28.11K
State Street® SPDR® S&P® Biotech ETF3.12M1.63%-31.20K
Eventide Healthcare & Life Sciences I2.68M1.56%-
JPMorgan Small Cap Growth A2.20M1.29%32.86K
SPDR® S&P Biotech ETF2.22M1.29%4.95K
Vanguard Small Cap Index2.02M1.18%7.50K
Belfius Equities Cure C Cap1.73M1.02%-

Recent Insider Transactions

DateNameRoleActivityValue
May 14, 2026Catinazzo Thomas Chief Financial OfficerSell$227.84K
Apr 28, 2026Catinazzo Thomas Chief Financial OfficerSell$14.38K
Apr 28, 2026Rahmer Peter See remarksSell$11.14K
Apr 28, 2026Bergstrom Donald A President, R&DSell$22.04K
Apr 07, 2026Catinazzo Thomas Chief Financial OfficerSell$230.50K

Insider Transactions Trends

DateBuySell
2026 Q2-6
2026 Q1-8
2025 Q4-5
2025 Q3-10
2025 Q2-12

RLAY Ownership FAQ

Who Owns Relay Therapeutics?

Relay Therapeutics shareholders are primarily institutional investors at 21.69%, followed by 1.57% insiders and 76.74% retail investors. The average institutional ownership in Relay Therapeutics's industry, Biotech Stocks , is 35.75%, which Relay Therapeutics falls below.

Who owns the most shares of Relay Therapeutics?

Relay Therapeutics’s largest shareholders are Sb investment advisers (uk) (27.9M shares, 16.29%), Commodore capital lp (17M shares, 9.91%), and Casdin capital (14.42M shares, 8.40%). Together, they hold 34.60% of Relay Therapeutics’s total shares outstanding.

Does Blackrock own Relay Therapeutics?

Yes, BlackRock owns 7.94% of Relay Therapeutics, totaling 10.54M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 68.74M$. In the last quarter, BlackRock increased its holdings by 746.46K shares, a 7.62% change.

Who is Relay Therapeutics’s biggest shareholder by percentage of total assets invested?

Casdin capital is Relay Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.86% of its assets in 14.42M Relay Therapeutics shares, valued at 143.46M$.

Who is the top mutual fund holder of Relay Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Relay Therapeutics shares, with 4.41% of its total shares outstanding invested in 7.38M Relay Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools